<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ATransitional_measures</id>
	<title>Definition:Transitional measures - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ATransitional_measures"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Transitional_measures&amp;action=history"/>
	<updated>2026-07-03T09:21:59Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Transitional_measures&amp;diff=22780&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating definition</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Transitional_measures&amp;diff=22780&amp;oldid=prev"/>
		<updated>2026-03-31T17:39:50Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating definition&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📋 &amp;#039;&amp;#039;&amp;#039;Transitional measures&amp;#039;&amp;#039;&amp;#039; refer to temporary regulatory provisions that allow insurance companies to phase in new solvency or accounting requirements over a defined period, rather than complying with them in full from day one. The term is most closely associated with the [[Definition:Solvency II|Solvency II]] framework in the European Union, which introduced two key transitional mechanisms when it took effect on January 1, 2016: the transitional measure on [[Definition:Technical provisions|technical provisions]] (TMTP) and the transitional measure on the [[Definition:Risk-free rate|risk-free interest rate]] (TMIR). These provisions were designed to prevent abrupt disruptions to insurers&amp;#039; balance sheets — particularly for firms with large books of long-duration [[Definition:Life insurance|life insurance]] business — by smoothing the transition from legacy national solvency regimes (such as Solvency I in the EU or the Individual Capital Adequacy Standards in the [[Definition:United Kingdom|United Kingdom]]) to the new risk-based capital framework. While transitional measures exist in various forms across global regulatory regimes, the Solvency II transitionals are by far the most prominent and widely discussed in industry practice.&lt;br /&gt;
&lt;br /&gt;
🔄 Under Solvency II, the TMTP works by allowing insurers to recognize a portion of the difference between their technical provisions calculated under the old national regime and those calculated under Solvency II, with this adjustment decreasing linearly over a sixteen-year period ending on January 1, 2032. In practical terms, this means an insurer&amp;#039;s [[Definition:Solvency capital requirement (SCR)|solvency capital requirement]] compliance position benefits from a gradually shrinking cushion. The TMIR operates similarly, permitting firms to blend the old discount rates used under prior regimes with Solvency II&amp;#039;s prescribed [[Definition:Risk-free rate|risk-free rate]] curve, again tapering to zero over the same sixteen-year horizon. Regulators — including the [[Definition:Prudential Regulation Authority (PRA)|Prudential Regulation Authority]] in the UK and national competent authorities across the EU — must approve the use of these measures and can require firms to recalculate the transitional adjustment when the risk profile of the business changes materially. In the UK, post-Brexit reforms to the Solvency II framework (sometimes referred to as [[Definition:Solvency UK|Solvency UK]]) have revisited the calibration and role of transitional measures, reflecting a broader debate about how quickly insurers should converge to full compliance with reformed capital standards.&lt;br /&gt;
&lt;br /&gt;
⚖️ The significance of transitional measures extends well beyond regulatory technicality — they directly affect the reported financial strength of some of the largest insurance groups in Europe and the UK. Analysts, rating agencies, and investors scrutinize the size of an insurer&amp;#039;s transitional benefit closely, because stripping it away reveals the &amp;quot;fully loaded&amp;quot; solvency position, which can be substantially lower. A firm that appears comfortably capitalized on a transitional basis may look far more constrained without it, and this distinction shapes investment decisions, [[Definition:Mergers and acquisitions (M&amp;amp;A)|M&amp;amp;A]] valuations, and regulatory supervisory intensity. The gradual run-off of transitional measures also creates strategic pressure: insurers must either earn their way to full compliance through organic capital generation, adjust their asset or liability portfolios, or pursue transactions such as [[Definition:Part VII transfer|Part VII transfers]] or [[Definition:Reinsurance|reinsurance]] restructurings to manage the transition. As the 2032 deadline approaches, the industry&amp;#039;s reliance on these measures — and the consequences of their expiration — will become an increasingly important theme in European and UK insurance capital management.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Technical provisions]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Risk-free rate]]&lt;br /&gt;
* [[Definition:Prudential Regulation Authority (PRA)]]&lt;br /&gt;
* [[Definition:Matching adjustment]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>